Stockreport

Tarsus Announces Proposed $100.0 Million Public Offering

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF IRVINE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and [Read more]